ACLX — ARCELLX INC

Ownership history in STEMPOINT CAPITAL LP  ·  10 quarters on record

This page tracks every 13F SEC filing in which STEMPOINT CAPITAL LP reported a position in ARCELLX INC (ACLX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
5.73% (2025 Q1)
Avg. % of fund
2.73%
First filed
2023 Q4
Last filed
2025 Q4
Quarters held
10
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 332,860 +321,484 +2826.0% 3.72% $21.7M $65.20
2025 Q3 REDUCED 11,376 -190,076 -94.4% 0.19% $934K $82.10
2025 Q2 REDUCED 201,452 -72,322 -26.4% 4.26% $13.3M $65.85
2025 Q1 ADDED 273,774 +213,698 +355.7% 5.73% $18.0M $65.60
6 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    ACLX price (monthly, adj. close)

Other funds also holding ACLX

As of 2025 Q4 — sorted by position size

GILEAD SCIENCES, INC. 22.64% SR ONE CAPITAL MANAGEMENT, LP 3Y 21.66% NEA Management Company, LLC 3Y 7Y 10.12% Paradigm Biocapital Advisors LP 3Y 9.53% Vestal Point Capital, LP 6.48% Affinity Asset Advisors, LLC 3Y 1.95% Catalio Capital Management, LP 1.8% PERCEPTIVE ADVISORS LLC 3Y 7Y 1.7% HighVista Strategies LLC 3Y 7Y 1.26% Atle Fund Management AB 3Y 7Y 0.87%
← Back to STEMPOINT CAPITAL LP Holdings